Big Move For CytoMed Therapeutics Limited
Tue, Jul 11, 2023 at 07:44 PM
CytoMed Therapeutics Limited (GDTC:NASDAQ) rocketted at $5.64, representing a gain of 61.6%. On Tue, Jul 11, 2023, GDTC:NASDAQ hit a New 2-Week High of $5.64. The stock got featured on our News Catalysts scanner on Thu, Jul 06, 2023 at 09:43 AM in the 'BIOTECH' category. From Tue, Jun 27, 2023, the stock recorded 77.78% Up Days and 60.00% Green Days
The stock spiked on Tue, Jul 11, 2023 at $9.25 with a volume of 21M+.
About CytoMed Therapeutics Limited (GDTC:NASDAQ)
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human...
Top 10 Gainers:
- PainReform Ltd. (PRFX:NASDAQ), 307.41%
- Adial Pharmaceuticals, Inc. (ADIL:NASDAQ), 90.31%
- CytoMed Therapeutics Limited (GDTC:NASDAQ), 61.6%
- Yellow Corporation (YELL:NASDAQ), 45.15%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 42.22%
- Freeline Therapeutics Holdings plc (FRLN:NASDAQ), 38.43%
- Knightscope Inc. (KSCP:NASDAQ), 36.6%
- Taoping Inc. (TAOP:NASDAQ), 32.58%
- SOS Limited American Depositary Shares (SOS:NYSE), 31.17%
- UTime Limited (UTME:NASDAQ), 28.86%